AJOVY

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, New Zealand, Poland, Romania, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug AJOVY contains one active pharmaceutical ingredient (API):

1 Fremanezumab UNII PF8K38CG54 - FREMANEZUMAB

Fremanezumab is a humanised IgG2Δa/kappa monoclonal antibody which selectively binds the calcitonin gene-related peptide (CGRP) ligand and blocks both CGRP isoforms (α- and β-CGRP) from binding to the CGRP receptor. It is believed that prevention of migraine is obtained by its effect modulating the trigeminal system. Read about Fremanezumab

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
AJOVY Solution for injection	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N02CD03		N Nervous system → N02 Analgesics → N02C Antimigraine preparations → N02CD Calcitonin gene-related peptide (CGRP) antagonists
Discover more medicines within N02CD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 537520050008907, 537520050009007
Country: CA	Health Products and Food Branch	Identifier(s): 02497859
Country: EE	Ravimiamet	Identifier(s): 1791615, 1791626
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1191358001
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 176721, 416492
Country: FR	Base de données publique des médicaments	Identifier(s): 68696906
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 372224, 386539
Country: HK	Department of Health Drug Office	Identifier(s): 67139
Country: IE	Health Products Regulatory Authority	Identifier(s): 89094, 89109
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8464
Country: JP	医薬品医療機器総合機構	Identifier(s): 1190407G1023, 1190407G2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1087474, 1087475, 1089296, 1089297
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 21711
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100417464
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W65973001, W65973002, W68419001, W68419002
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699638955701, 8699638955718
Country: US	FDA, National Drug Code	Identifier(s): 51759-202, 51759-204
Country: ZA	Health Products Regulatory Authority	Identifier(s): 54/30.1/0711